cytoreduction

(redirected from cytoreductive therapy)
Also found in: Medical.
Related to cytoreductive therapy: Anagrelide, tumor debulking
Translations

cy·to·re·duc·tion

n. destrucción de celulas, gen. células cancerosas clonos por medio de quimioterapia.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
Keytruda is not recommended for the treatment of patients with PMBCL who require urgent cytoreductive therapy.
Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating Keytruda as Monotherapy and in Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
(1,2,6,8,9) Among patients with either hematologic or solid tumors, bulky disease and tumors that are highly sensitive to cytoreductive therapy pose the greatest risk of TLS.
Tumor Lysis Syndrome
KEYTRUDA is not recommended for the treatment of patients with PMBCL who require urgent cytoreductive therapy. With this indication, KEYTRUDA becomes the first anti-PD-1 therapy to be approved for the treatment of PMBCL, a type of non-Hodgkin lymphoma.
Merck: FDA approves KEYTRUDA for treatment of refractory, relapsed PMBCL
In addition, cytoreductive therapy was recommended for high-risk ET patients.[7] Except for case 3, who refused the procedure, the others were administered contemporary cytoreduction (HU or IFN-a) and antithrombotic therapy, which revealed favorable long-term outcomes.
Cerebral Venous Sinus Thrombosis as the First Manifestation of JAK2V617F-positive Essential Thrombocythemia
In our case, a lack of awareness of this phenomenon led to several changes in the antimicrobial regimen and delayed the initiation of appropriate cytoreductive therapy.
False-Positive Blood Cultures in Acute Leukemia: An Underrecognized Finding
Surgery with cytoreductive therapy and intraperitoneal chemotherapy is the approach with better outcomes described.
Mucinous Carcinomatosis: A Rare Association between an Ovarian Tumor and an E-GIST
Cytoreductive therapy is not recommended as initial treatment.
Myeloproliferative Neoplasms
The patient had no previous incidents of thrombosis or hemorrhage; however as she was older than 65 years cytoreductive therapy with hydroxyurea (HU) has been introduced.
Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report
Dictionary browser ?
Full browser ?